Skip to content

Medical emergency? What to do

Merck gains on US approval for combo diabetes pill

3-RXPublished April 3, 20071 min read

Key points

  • Shares of Merck & Co. rose on Monday after the company won U.S. marketing approval for Janumet, which combines its recently introduced Januvia diabetes drug in the same tablet with the widely used metformin treatment.
  • Janumet, by combining Januvia and metformin into a single product, is meant to help patients with Type 2 diabetes better control their blood sugar.
  • Food and Drug Administration in October approved use of Januvia either by itself or alongside metformin or another class of medicines called thiazolidinediones (TZDs) to treat type 2 diabetes.
  • "Over time, we wouldn't be surprised if Janumet overtakes Januvia as the preferred drug in its class as potency on the combined agent is superior to the single-agent pill," Morgan Stanley analyst Jami Rubin said in a research note.

Shares of Merck & Co. rose on Monday after the company won U.S. marketing approval for Janumet, which combines its recently introduced Januvia diabetes drug in the same tablet with the widely used metformin treatment.

Merck was up 74 cents, or 1.7 percent, to $44.91, in midday trade on the New York Stock Exchange, amid slight gains for the drug sector.

Janumet, by combining Januvia and metformin into a single product, is meant to help patients with Type 2 diabetes better control their blood sugar. That most common form of diabetes is highly linked with obesity.

Metformin, a member of the biguanide class of oral treatments, is the most widely used-diabetic drug in the United States. It was introduced more than a decade ago by Bristol-Myers Squibb Co. under the brand name Glucophage, but is now sold by many generic drugmakers.

The U.S. Food and Drug Administration in October approved use of Januvia either by itself or alongside metformin or another class of medicines called thiazolidinediones (TZDs) to treat type 2 diabetes.

Analysts have predicted Januvia, a member of a new class of drugs called DPP-4 inhibitors, would become a blockbuster medicine with annual sales of more than $1 billion.

"Over time, we wouldn't be surprised if Janumet overtakes Januvia as the preferred drug in its class as potency on the combined agent is superior to the single-agent pill," Morgan Stanley analyst Jami Rubin said in a research note.

She said combined annual sales of Januvia and Janumet are likely to reach $2.8 billion by 2011.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Keep reading

Drug News

Drug shows early promise in treating seizures

A study out today in the journal Nature Medicine suggests a potential new treatment for the seizures that often plague children with genetic metabolic disorders and individuals undergoing liver failure. The discovery…

5 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.